Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Genedrive set to apply for NICE EVA funding

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR). The AIM-traded firm said the initiative, in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), aimed to bridge real-world evidence gaps to expedite the widespread adoption of technologies endorsed for use in the NHS through the NICE EVA framework.

It said the Real World Evidence Programme, supported by £10m of government funding as part of the government's 'Life Sciences Vision', was intended to accelerate the integration of recommended technologies into healthcare practices.

In response, Genedrive said it intended to submit an application for funding.

The company said it was aiming to address the NICE EVA evidence generation recommendations concerning the Genedrive MT-RNR1 ID Kit.

"We are delighted that funding is to be made available for the real world evidence generation for the NICE EVA technologies to achieve full NICE guidance," said chief executive officer James Cheek.

"This gives the potential for our Genedrive MT-RNR1 ID Kit to move from a conditional recommendation to a full recommendation with NICE, and accelerate adoption of the kit in the NHS."

At 1126 GMT, shares in Genedrive were up 1.62% at 4.7p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Royal Mail-owner rebuffs takeover approach
(Sharecast News) - Shares in International Distribution Services soared on Wednesday, after it emerged that Czech billionaire Daniel Kretinsky had made a takeover approach for the Royal Mail owner.
Just Eat shares drop as Q1 orders disappoint
(Sharecast News) - Shares in Just Eat dropped sharply on Wednesday after the food delivery marketplace delivered underwhelming order numbers for the first quarter, though revenue growth picked up sharply in the UK and Ireland.
Tekcapital's Innovative Eyewear inks deal with US firm
(Sharecast News) - Intellectual property investor Tekcapital announced a fresh development from its portfolio company Innovative Eyewear on Wednesday, as the latter launched a strategic partnership with Windsor Eyes, a prominent eyewear manufacturing and distribution firm.
Eckoh expanding availability of voice cloud platform
(Sharecast News) - Eckoh announced on Wednesday that it has augmented its global secure voice cloud platform, enhancing its availability and geographic coverage.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.